DECLINE v1.0
Research type
Research Study
Full title
DECLINE: Decisions against curative treatment for lung cancer in eligible patients
IRAS ID
302336
Contact name
Manpreet Bains
Contact email
Sponsor organisation
University of Nottingham
Duration of Study in the UK
1 years, 10 months, 31 days
Research summary
A significant number of patients who seem to be suitable for treatment that may cure them of their lung cancer do not receive that treatment, and we do not know why this is or whether anything can be done about it. One reason might be the patient’s own choice. A previous interview study, conducted by members of this research team, looked at attitudes towards risk of surgery in lung cancer patients and found that confidence in the surgeon was particularly important to people deciding whether to undergo treatment, more important than the risk of the operation. Another factor might be distance because we know that people who live long distances from where treatment is given tend to have less treatment. Research is needed to look in detail at what it is that makes people with early stage curable lung cancer make decisions that seem to their disadvantage. We need to find out if there are ways that we can get more people to have the best possible treatment, by explaining things better, supporting them to make their decision, educating health care staff and sorting out any practical issues that may exist.
REC name
West Midlands - Edgbaston Research Ethics Committee
REC reference
21/WM/0263
Date of REC Opinion
13 Dec 2021
REC opinion
Further Information Favourable Opinion